Reasons behind the rising rate of involuntary admissions under the Mental Health Act (1983): Service use and cost impact.


Journal

International journal of law and psychiatry
ISSN: 1873-6386
Titre abrégé: Int J Law Psychiatry
Pays: Netherlands
ID NLM: 7806862

Informations de publication

Date de publication:
Historique:
received: 24 03 2019
revised: 29 09 2019
accepted: 03 10 2019
entrez: 9 2 2020
pubmed: 9 2 2020
medline: 13 2 2021
Statut: ppublish

Résumé

There has been a significant rise in the use of the Mental Health Act (1983) in England over the last 10 years. This includes both health-based Place of Safety detentions and involuntary admissions to NHS mental health facilities. Although these trends should clearly inform the implementation of mental health care and legislation, there is currently little understanding of what caused these increased rates. We therefore sought to explore potential underlying reasons for the increase in involuntary admissions and Place of Safety detentions and to ascertain the associated service costs. We extracted publicly available data to ascertain the observed number of involuntary admissions (Section 2 or 3) and health-based Place of Safety detentions in England between 1999/2000 and 2015/2016. A simple regression analysis then enabled us to compare observed admission rates with predicted rates, between 2008/2009 and 2015/2016. This prediction model was based on observed figures before 2008. We then generated a costing model for these rates and compared admission costs to alternative interventions. Finally, we added relevant covariates to the prediction model, to explore potential relationships with observed rates. Since 2008/2009, there has been a marked increase in the number of involuntary admissions (38%) and Place of Safety detentions (617%). The analysis revealed that for involuntary admissions, the period of greatest increase occurred after 2012, two years after austerity measures were implemented. For Place of Safety detentions, substantial rises were seen from 2008/2009 to 2015/2016, coinciding with the economic recession. The rise in Place of Safety detentions may have been worsened by a reduction in mental health bed availability. During the study period, involuntary admissions are estimated to have cost the English NHS £6.8 billion; with a further £120 million spent on Place of Safety detentions. This is approximately £597 million greater than predicted, had involuntary admissions continued to change at pre-2008 rates. We conclude that the rise in involuntary admissions, and to a lesser extent Place of Safety detentions, were associated with three specific impactful events: the economic recession, legislative changes and the impact of austerity measures on health and social care services. In addition to the extensive arguments presented elsewhere, there is also an urgent economic case for addressing this trend.

Identifiants

pubmed: 32033706
pii: S0160-2527(19)30049-4
doi: 10.1016/j.ijlp.2019.101506
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101506

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Shubulade Smith (S)

Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, De Crespigny Park, London SE5 8AF, UK; South London and Maudsley NHS Foundation Trust, Maudsley Hospital, Denmark Hill, Camberwell, London SE5 8AZ, UK; National Collaborating Centre for Mental Health, Royal College of Psychiatrists, 21 Prescot Street, London E1 8BB, UK. Electronic address: Shubulade.smith@kcl.ac.uk.

Rebecca Gate (R)

National Collaborating Centre for Mental Health, Royal College of Psychiatrists, 21 Prescot Street, London E1 8BB, UK.

Kevin Ariyo (K)

National Collaborating Centre for Mental Health, Royal College of Psychiatrists, 21 Prescot Street, London E1 8BB, UK; Centre for Outcomes Research and Effectiveness, Department of Clinical Educational and Health Psychology, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.

Rob Saunders (R)

Centre for Outcomes Research and Effectiveness, Department of Clinical Educational and Health Psychology, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.

Clare Taylor (C)

National Collaborating Centre for Mental Health, Royal College of Psychiatrists, 21 Prescot Street, London E1 8BB, UK.

Kamaldeep Bhui (K)

Centre for Psychiatry, Wolfson Institute of Preventative Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Ifigeneia Mavranezouli (I)

Centre for Outcomes Research and Effectiveness, Department of Clinical Educational and Health Psychology, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.

Margaret Heslin (M)

Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, De Crespigny Park, London SE5 8AF, UK.

Helen Greenwood (H)

National Collaborating Centre for Mental Health, Royal College of Psychiatrists, 21 Prescot Street, London E1 8BB, UK.

Hannah Matthews (H)

Centre for Outcomes Research and Effectiveness, Department of Clinical Educational and Health Psychology, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.

Phoebe Barnett (P)

Centre for Outcomes Research and Effectiveness, Department of Clinical Educational and Health Psychology, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.

Stephen Pilling (S)

National Collaborating Centre for Mental Health, Royal College of Psychiatrists, 21 Prescot Street, London E1 8BB, UK; Centre for Outcomes Research and Effectiveness, Department of Clinical Educational and Health Psychology, University College London, 1-19 Torrington Place, London WC1E 7HB, UK; Camden & Islington NHS Foundation Trust, 4 St Pancras Way, London NW1 0PE, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH